Cyropreserved amniotic membrane option for management of DED, NK
Ophthalmology Times,
Treatment requires a systematic, multifaceted approach to improve outcomes. (Image Credit: AdobeStock/sola_sola) Dry eye…
Treatment requires a systematic, multifaceted approach to improve outcomes. (Image Credit: AdobeStock/sola_sola) Dry eye…
BRIM Biotechnology, Inc., a company established in July 2013 to accelerate the development and transformation of early research…
Taipei, Taiwan, 8th December 2022 / Sciad Newswire / BRIM Biotechnology, Inc. ("BRIM," TPEx 6885) is pleased to announce that…
Taipei, Taiwan, 8th December 2022 / Sciad Newswire / BRIM Biotechnology, Inc. ("BRIM," TPEx 6885) is pleased to announce that…